The North America Congestive Heart Failure (CHF) Treatment Devices Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
Congestive heart failure, or CHF, is a chronic progressive condition that impacts the pumping ability of the heart muscle. Congestive heart failure treatment devices are instruments that are used to treat patients with CHF. Mechanical circulatory support devices are used to treat congestive heart failure. Pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices, and ventricular assist devices are examples of congestive heart failure therapeutic equipment. Implantable cardiac defibrillators are electronic devices that are implanted into the body. An ICD (implantable cardiac defibrillator) continuously monitors heart rhythm and, if it becomes abnormal, delivers a mild shock to the heart muscle.
A ventricular assist device aids in pumping the blood from the heart's lower chambers to the rest of the body. There are also several types of ventricular assist devices, including left congestive heart failure treatment devices (LVADs), right congestive heart failure treatment devices (RVADs), and others. Because weak left ventricular muscles are widespread among patients with congestive heart failure, left congestive heart failure therapy devices are the most widely utilized VADs. They have been employed as a long-term therapy for people with only a slim likelihood of improving their cardiac muscles. Right congestive heart failure therapy devices (RVADs) pump blood from the right ventricle to the pulmonary aorta. When compared to instances requiring an LVAD, such occurrences are quite uncommon.
Some of the factors driving market expansion in the North American region include increased demand for congestive heart failure (CHF) treatments, high health expenditures, rising prevalence of target illnesses, and increased population awareness regarding treatment device availability. According to the Centers for Disease Control and Prevention, COVID-19 patients with an underlying cardiac issue are still more likely to become severely ill. Moreover, supportive sickness awareness campaigns are anticipated to help the cardiovascular devices market in North America. In addition, according to the National Library of Medicine, CV disorders are a severe health burden for Canadians. About one-third of Canadians die from heart attacks and strokes, and CV diseases account for nearly 16% of hospitalizations.
This illness load has a significant economic impact, with CV disorders accounting for more than $22 billion indirect and direct expenditures in 2000. Despite these figures, the mortality rates for heart attacks and strokes have dropped dramatically in recent decades, and the number of Canadians dying from CV disorders has lately decreased. Some of the risk factors for cardiovascular disease are becoming more common at an alarming rate. Obesity is on the rise, especially among the young, and this is expected to lead to more diabetes, hypertension, and lipid abnormalities, which would result in more heart attacks and strokes.
The US market dominated the North America Congestive Heart Failure (CHF) Treatment Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,234.7 Million by 2028. The Canada market is experiencing a CAGR of 7.3% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 6.3% during (2022 - 2028).
Based on Product Type, the market is segmented into Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Congestive Heart Failure (CHF) Treatment Devices Market is Predict to reach $16.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott Laboratories, Medtronic PLC, Abiomed, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, and Osypka Medical GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Pacemakers
- Implantable Cardioverter Defibrillators
- Cardiac Resynchronization Therapy
- Ventricular Assist Devices
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- Abiomed, Inc.
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- Lepu Medical Technology (Beijing) Co., Ltd.
- BIOTRONIK SE & Co. KG
- Osypka Medical GmbH
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 North America Congestive Heart Failure (CHF) Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
Chapter 4. North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 North America Pacemakers Market by Country
4.2 North America Implantable Cardioverter Defibrillators Market by Country
4.3 North America Cardiac Resynchronization Therapy Market by Country
4.4 North America Ventricular Assist Devices Market by Country
Chapter 5. North America Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1 US Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 Canada Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 Mexico Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview
TABLE 1 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 2 North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 4 Product Launches And Product Expansions– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 5 Acquisition and Mergers– Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 6 Approvals and Trials - Congestive Heart Failure (CHF) Treatment Devices Market
TABLE 7 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 8 North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 9 North America Pacemakers Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Pacemakers Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Implantable Cardioverter Defibrillators Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Implantable Cardioverter Defibrillators Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Cardiac Resynchronization Therapy Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Cardiac Resynchronization Therapy Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Ventricular Assist Devices Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Ventricular Assist Devices Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Congestive Heart Failure (CHF) Treatment Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 US Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 20 US Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 21 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 22 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 23 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 24 Canada Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 25 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 26 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 27 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 28 Mexico Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 29 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 30 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 31 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2018 - 2021, USD Million
TABLE 32 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market, 2022 - 2028, USD Million
TABLE 33 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2018 - 2021, USD Million
TABLE 34 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type, 2022 - 2028, USD Million
TABLE 35 key Information – Boston Scientific Corporation
TABLE 36 key Information – MicroPort Scientific Corporation
TABLE 37 Key Information – Abbott Laboratories
TABLE 38 Key Information – Medtronic PLC
TABLE 39 Key Information – ABIOMED, Inc.
TABLE 40 Key Information – Berlin Heart GmbH
TABLE 41 Key Information – JARVIK HEART, INC.
TABLE 42 Key Information – Lepu Medical Technology (Beijing) Co., Ltd.
TABLE 43 Key Information – BIOTRONIK SE & Co. KG
TABLE 44 Key Information – Osypka Medical GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players
FIG 5 Recent strategies and developments: Boston Scientific Corporation
FIG 6 Recent Strategies and Developments: MicroPort Scientific Corporation
FIG 7 Recent strategies and developments: Abbott Laboratories
FIG 8 Recent strategies and developments: Abiomed, Inc.